Values of serum sFlt-1, PLGF levels, and sFlt-1/PLGF ratio in diagnosis and prognosis evaluation of preeclamptic patients

Purpose To explore the values of serum sFlt-1, PLGF levels and sFlt-1/PLGF ratio in the diagnosis and prognosis evaluation of preeclamptic patients. Methods From March 2017 to October 2018, 60 cases of early onset preeclampsia (E-PE), 116 cases of late onset preeclampsia (L-PE) and 50 cases of gesta...

Full description

Bibliographic Details
Main Authors: Xiaohe Zhu, Limin Chen, Ran Li
Format: Article
Language:English
Published: Taylor & Francis Group 2020-10-01
Series:Clinical and Experimental Hypertension
Subjects:
Online Access:http://dx.doi.org/10.1080/10641963.2020.1756313
_version_ 1797681319564541952
author Xiaohe Zhu
Limin Chen
Ran Li
author_facet Xiaohe Zhu
Limin Chen
Ran Li
author_sort Xiaohe Zhu
collection DOAJ
description Purpose To explore the values of serum sFlt-1, PLGF levels and sFlt-1/PLGF ratio in the diagnosis and prognosis evaluation of preeclamptic patients. Methods From March 2017 to October 2018, 60 cases of early onset preeclampsia (E-PE), 116 cases of late onset preeclampsia (L-PE) and 50 cases of gestational hypertension (GH) were selected. Fifty women who had vaginal bleeding or abdominal distention before 34 gestational weeks were selected as an early control group, and 50 pregnant women awaiting delivery were selected as a late control group. Serum sFlt-1 and PLGF levels were measured, and changes of sFlt-1/PLGF ratio were analyzed. Their correlations with neonatal birth weight were analyzed, and ROC curves were plotted for E-PE diagnosis. Results The sFlt-1/PLGF ratio of patients with E-PE was significantly higher than those of other groups, and negatively correlated with neonatal birth weight. When the ratio was used as a diagnostic index, AUC was 0.975. The ratio of patients with severe L-PE exceeded that of cases with mild L-PE. In all preeclamptic patients, the ratio was elevated with increasing maternal and neonatal complications. Conclusion sFlt-1/PLGF ratio is valuable for assessing the severity of preeclampsia and diagnosing E-PE, and can be used to predict neonatal birth weight.
first_indexed 2024-03-11T23:43:13Z
format Article
id doaj.art-b3f5b0facfb945068d883d570952015a
institution Directory Open Access Journal
issn 1064-1963
1525-6006
language English
last_indexed 2024-03-11T23:43:13Z
publishDate 2020-10-01
publisher Taylor & Francis Group
record_format Article
series Clinical and Experimental Hypertension
spelling doaj.art-b3f5b0facfb945068d883d570952015a2023-09-19T15:19:29ZengTaylor & Francis GroupClinical and Experimental Hypertension1064-19631525-60062020-10-0142760160710.1080/10641963.2020.17563131756313Values of serum sFlt-1, PLGF levels, and sFlt-1/PLGF ratio in diagnosis and prognosis evaluation of preeclamptic patientsXiaohe Zhu0Limin Chen1Ran Li2Shandong Weifang People’s HospitalShandong Weifang People’s HospitalShandong Weifang People’s HospitalPurpose To explore the values of serum sFlt-1, PLGF levels and sFlt-1/PLGF ratio in the diagnosis and prognosis evaluation of preeclamptic patients. Methods From March 2017 to October 2018, 60 cases of early onset preeclampsia (E-PE), 116 cases of late onset preeclampsia (L-PE) and 50 cases of gestational hypertension (GH) were selected. Fifty women who had vaginal bleeding or abdominal distention before 34 gestational weeks were selected as an early control group, and 50 pregnant women awaiting delivery were selected as a late control group. Serum sFlt-1 and PLGF levels were measured, and changes of sFlt-1/PLGF ratio were analyzed. Their correlations with neonatal birth weight were analyzed, and ROC curves were plotted for E-PE diagnosis. Results The sFlt-1/PLGF ratio of patients with E-PE was significantly higher than those of other groups, and negatively correlated with neonatal birth weight. When the ratio was used as a diagnostic index, AUC was 0.975. The ratio of patients with severe L-PE exceeded that of cases with mild L-PE. In all preeclamptic patients, the ratio was elevated with increasing maternal and neonatal complications. Conclusion sFlt-1/PLGF ratio is valuable for assessing the severity of preeclampsia and diagnosing E-PE, and can be used to predict neonatal birth weight.http://dx.doi.org/10.1080/10641963.2020.1756313sflt-1plgfsflt-1/plgffetal growth restrictionpreeclampsia
spellingShingle Xiaohe Zhu
Limin Chen
Ran Li
Values of serum sFlt-1, PLGF levels, and sFlt-1/PLGF ratio in diagnosis and prognosis evaluation of preeclamptic patients
Clinical and Experimental Hypertension
sflt-1
plgf
sflt-1/plgf
fetal growth restriction
preeclampsia
title Values of serum sFlt-1, PLGF levels, and sFlt-1/PLGF ratio in diagnosis and prognosis evaluation of preeclamptic patients
title_full Values of serum sFlt-1, PLGF levels, and sFlt-1/PLGF ratio in diagnosis and prognosis evaluation of preeclamptic patients
title_fullStr Values of serum sFlt-1, PLGF levels, and sFlt-1/PLGF ratio in diagnosis and prognosis evaluation of preeclamptic patients
title_full_unstemmed Values of serum sFlt-1, PLGF levels, and sFlt-1/PLGF ratio in diagnosis and prognosis evaluation of preeclamptic patients
title_short Values of serum sFlt-1, PLGF levels, and sFlt-1/PLGF ratio in diagnosis and prognosis evaluation of preeclamptic patients
title_sort values of serum sflt 1 plgf levels and sflt 1 plgf ratio in diagnosis and prognosis evaluation of preeclamptic patients
topic sflt-1
plgf
sflt-1/plgf
fetal growth restriction
preeclampsia
url http://dx.doi.org/10.1080/10641963.2020.1756313
work_keys_str_mv AT xiaohezhu valuesofserumsflt1plgflevelsandsflt1plgfratioindiagnosisandprognosisevaluationofpreeclampticpatients
AT liminchen valuesofserumsflt1plgflevelsandsflt1plgfratioindiagnosisandprognosisevaluationofpreeclampticpatients
AT ranli valuesofserumsflt1plgflevelsandsflt1plgfratioindiagnosisandprognosisevaluationofpreeclampticpatients